In Segment A, individuals will get unique doses and schedules of oral ABBV-744 pill to recognize Harmless dosing regimen. Added contributors is going to be enrolled within the identified monotherapy dosign routine. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "include-on" therapy. In Section https://theodorf444teo7.ourabilitywiki.com/user